PGNY Stock Analysis: Buy, Sell, or Hold?
PGNY - Progyny, Inc. Common Stock
$31.56
0.03 (0.10%)
▲
5d:
+2.6%
30d:
+2.04%
90d:
+66.9%
BUY
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 06, 2026
1d
Get Alerted When PGNY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PGNY shows positive signals but monitor for confirmation. Market pricing in 7.5% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: PGNY shows positive signals but monitor for confirmation. Market pricing in 7.5% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.02
Based on 6.7% avg growth
INTRINSIC VALUE TODAY
$21.74
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PGNY is currently trading at $31.56, which is considered slightly high relative to its 30-day fair value range of $29.98 to $32.04. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.0) compared to its historical average (11.3). At these levels, the market is pricing in 7.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PGNY is in a strong uptrend. Immediate support is located at $29.93, while resistance sits at $32.70.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PGNY is in a strong uptrend. Immediate support is located at $29.93, while resistance sits at $32.70.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$29.98 -
$32.04
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
67.3%
All Signals
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($34.00)
- NEUTRAL: Trading at premium valuation - market expects 7.5% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$29.98 -
$32.04
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$2.46
(7.8%)
Support & Resistance Levels
Support Level
$29.93
Resistance Level
$32.70
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.03
Wall Street Target
$34.00
(+7.8%)
Revenue Growth (YoY)
1.4%
Earnings Growth (YoY)
70.6%
Profit Margin
5.2%
Valuation Premium vs History
+7.5% premium
PE vs Historical
14.0 vs 11.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.5%
(market-implied from PE analysis)
1-Year Target
$33.89
(+8%)
2-Year Target
$36.44
(+16%)
3-Year Target
$39.17
(+24%)
3-Yr Target (if PE normalizes)
(PE: 14→11)
PE COMPRESSION
$31.55
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 9.3%)
$60.83
(+93%)
Base:
(SPY PE: 14.0, Growth: 9.3%)
$41.16
(+31%)
Bear:
(PE: 11.3, Growth: 9.3%)
$33.16
(+5%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (40x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 40.43 | Current EPS (TTM): $0.77
Bull Case
$68.49
(+117%)
Analyst growth 100.0%, PE expands to 44.5
Base Case
$62.26
(+98%)
Market implied 100.0%, PE stable at 40.4
Bear Case
$21.17
(-33%)
Severe decline -20.0%, PE contracts to 34.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 04, 2026 12:11 PM ET
Data refreshes hourly during market hours. Next update: 1:11 PM
Data refreshes hourly during market hours. Next update: 1:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PGNY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Allison Swartz
SELL
599 shares
2026-03-04
Allison Swartz
SELL
4657 shares
2026-03-03
Allison Swartz
SELL
2199 shares
2026-03-02
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$114 | 52 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$475 | 49 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$343 | 47 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$449 | 55 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$408 | 57 HOLD |
Advanced PGNY Option Strategies
Professional options setups generated by AI based on today's PGNY price and gamma walls.
